Conversely, treatment of RencaLuM2b cells with DMH1, a small molecule inhibitor of the BMP receptors, reversed the inhibitory effect of Laptm5 knockdown on tumor sphere formation (Supplementary Fig. 6e and Fig. 4h), suggesting the function of LAPTM5 was BMP-dependent. The gene discussed is LAPTM5; the disease is neoplasm.